Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2012-04-30
- Lead Sponsor
- Gerhard Treiber
- Target Recruit Count
- 33
- Registration Number
- NCT00775073
- Locations
- 🇩🇪
Medizinische Klinik 1 University of Erlangen, Erlangen, Bavaria, Germany
🇩🇪Zollernalbklinikum, Balingen, Germany
🇩🇪Charité, Campus Virchow Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Berlin, Germany
News
No news found